The global inulin industry in prebiotics market was valued at over USD 2.05 billion in 2020 and is expected to grow at a CAGR of 9.9% over the assessment period (2021-2027). Inulin probiotics have been used to treat vaginal yeast infections, bowel problems (such as diarrhea, irritable bowel), lactose intolerance, eczema, and urinary tract infections. It offers multiple benefits like improved gut health, insulin stabilization, bowel function, appetite suppression, and heart health.
Request for a sample copy of this research report @ https://www.gminsights.com/request-sample/detail/410
As per a report published by Global Market Insights, the prebiotics market size is expected to surpass USD 9.5 billion by 2027.
Europe prebiotics market is expected to surpass USD 4 billion by 2027. Consumers in Europe are willingness to pay premium prices for quality prebiotics. The regional market will showcase extensive growth due to consumer awareness towards gut health for infants and adults. Budding consumption of confectionery, meat, bakery, and snack products without compromising on its nutritive value combined with an improved taste profile may drive the consumption of prebiotics .
Burgeoning demand for nutrient-rich and fiber food products could result in high demand for prebiotics market. Factors like rising disposable income, the ability of prebiotics to improve gut health, increasing working women population, and product innovations may contribute to its hightnened supply and production over the years.
The key players operating in the prebiotics market are Yakult Pharmaceutical Industry Co., SOLACTIS Group, Abbott Laboratories, Beneo GmbH, Friesland Campina, Dupont, Cargill, Inc., Ltd., and Jarrow Formulas, Inc. among others. Manufacturers and suppliers are constantly focusing on leveraging strategic initiatives like developing new products with better quality to cater to the growing consumer demand.
Request for customization @ https://www.gminsights.com/roc/410
The escalating need to treat medical conditions like constipation, diarrhea, and high cholesterol levels is expected to surge the demand for FOS (Fructo-oligosaccharides) in the pharmaceutical industry. Used as prebiotics, FOS act as a good bacteria for the intestine. It offers multiple benefits like decreased level of serum cholesterol, low carcinogenicity phospholipids, improved mineral absorption, and increased calcium absorption.
Rising incidences of digestive disorders and demand for products that contribute to healthly lifestyle may generate luncrative business opportunities for prebiotics suppliers. Prebiotics comprise of different type of micro-organisms such as bacteria and yeast. They are present in foods such as milk, juices, yogurt, soy beverages and are also available to consumers in the form of dietary supplements tablets, capsules, powders.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
Email: [email protected]